VRX Stock Forecast: Valeant Veers Away From Scandals, Rebrands Company

June 15, 2018
  This article was written by Julia Masch, a Financial Analyst at I Know First.




  Summary:

  • Q1 Highlights + Product Pipeline
  • Scandals + Valeant's Valiant Name Change
  • Current I Know First Forecast For VRX
premiumRead The Full Premium Article Subscribe to receive exclusive PREMIUM content here
52 Week High Stocks Biotech Stocks Forecast Pharma Stocks Forecast Premium Articles

Stock Price Valeant: Step by Step, Out of the Pit

July 25, 2017




This article was written by Mingyue Liu, a Financial Analyst at I Know First.

Valeant Pharmaceuticals International: Step by Step, Out of the Pit

"Medicine really matured me as a person because, as a physician, you're obviously dealing with life and death issues, issues much more serious than what we're talking about in entertainment. You can't get more serious than life and death. And if you can handle that, you can handle anything." (Ken Jeong)

Summary:
  • Debt divestiture through debt redemption and non-core business sales
  • Organic growth bolstered by potential launch of new drugs
  • Other tailwinds that may weigh on the company's growth

IBM priceRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here
Premium Articles